Press & Media
-
Hedge Funds Said One Thing. Their Portfolios Show Another.
We continue to track hedge funds’ exposure to quality. Based on the data, the last few months have seen a broad rotation out of high-quality names, and back into low-qualty ones.
-
Hedge Funds Are Betting the Stay-at-Home Play Is Over
As of the end of April, are managers long or short names like Zoom and Netflix?
-
Credit Hedge Funds Can’t Figure Out What They’re Worth
Typically, 70-80% of credit hedge funds report prior-month performance by this point – but that wasn’t the case for March 2020.
-
Credit Funds Lure Big Investors Betting on a 2009-Style Rebound
After years of scarce bankruptcies and extended borrowing by troubled companies, distressed opportunities, and the funds that invest in them, are on the rise.
-
Hedge Funds Lose in March But Not as Much as Stock Market
Multi-PM and long bias vol funds held up well in March, while credit, distressed and mortagage-backed funds suffered.
-
Credit Funds Expected to Scoop Up Assets Despite Big Name Loses
CEO Jon Caplis sat down with Business Insider mid-April 2020 to discuss our perspective on the credit space.
-
Did Hedge Funds Help Investors Survive March?
Hedge funds fared better than the broad market in March, while dispersion of net returns hit a record high.
-
Hedge Funds ‘Hang In There’ Amid Coronavirus Market Shock
The uncertainty and volatility created by the Coronavirus outbreak are leading to significant dispersion in hedge fund performance.
-
PivotalPath Creates COVID-19 Analysis Tool
We created a COVID-19 data-monitoring tool where our clients and fellow citizens can reference trusted data and stay informed.
-
Capacity Crunch Limits Tech, Healthcare Specialty Investing
CEO Jon Caplis spent time with Pensions & Investments to describe the strength of TMT and healthcare hedge fund returns, and alpha generated over the long-run.
